These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6006864)

  • 21. The early treatment diabetic retinopathy study.
    Rice TA
    Trans Pa Acad Ophthalmol Otolaryngol; 1982; 35(1):24-30. PubMed ID: 7051448
    [No Abstract]   [Full Text] [Related]  

  • 22. Morbidity and mortality in patients with diabetic retinopathy.
    Sharma NK; Archer DB; Hadden DR; Merrett JD; Maguire CJ
    Trans Ophthalmol Soc U K (1962); 1980 Apr; 100(Pt 1):83-9. PubMed ID: 6943838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
    Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes.
    Globocnik Petrovic M; Steblovnik K; Peterlin B; Petrovic D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):873-6. PubMed ID: 14704946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On diabetic retinopathy (clinical course)].
    Kojima K; Suzuki M
    Nihon Ganka Kiyo; 1966 Nov; 17(11):1099-108. PubMed ID: 6009704
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early diagnosis and therapy of diabetic retinopathy].
    Bodanowitz S; Kroll P
    Ther Umsch; 1996 Dec; 53(12):934-42. PubMed ID: 9036571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of HLA antigens with severity of diabetic retinopathy in Southern Germany.
    Standl E; Dexel T; Lander T; Albert ED; Scholz S; Greite JH; Janka HU; Mehnert H
    Horm Metab Res Suppl; 1981; 11():81-6. PubMed ID: 6947953
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetic retinopathy.
    Garrett CJ; Caird FI
    Curr Med Drugs; 1966 Oct; 7(2):11-6. PubMed ID: 5919068
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fluorescein angiography in diabetic retinopathy].
    Stîngu C; Cristescu A; Daraban C; Serghiescu S
    Oftalmologia; 2003; 56(1):15-9. PubMed ID: 12886675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for diabetic retinopathy in a diabetic management clinic.
    Sackett CS; Ferris FL
    J Ophthalmic Nurs Technol; 1982 Nov; 1(3):9-13. PubMed ID: 6922943
    [No Abstract]   [Full Text] [Related]  

  • 32. [HLA-markers and diabetic retinopathy in the Senegalese population].
    Cisse A; Chevenne D; Chauffert M; Ndiaye MR; Wade A; Trivin F
    Dakar Med; 1998; 43(1):29-33. PubMed ID: 9827151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ocular complications in diabetes: towards standardizing screening and care].
    Massin P
    Rev Prat; 2001 Oct; 51(16):1776-82. PubMed ID: 11795121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on ACE gene insertion/deletion polymorphism, serum ACE activity, and diabetic retinopathy in type II diabetic patients].
    Liao L; Lei M; Chen H; Han X; Fan C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):33-6. PubMed ID: 11938734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic retinopathy in Mauriac's syndrome. Paradoxical deterioration with improved metabolic control.
    Daneman D; Lobes LA; Becker DJ; Drash AL
    Retina; 1981; 1(2):84-7. PubMed ID: 7348825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic complications and the genetics of signal transduction. A study of retinopathy in NIDDM.
    Lucarini N; Bottini N; Antonacci E; Borgiani P; Faggioni G; Gloria-Bottini F
    Dis Markers; 1997 Nov; 13(3):169-76. PubMed ID: 9405929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship of angiotensin I-converting enzyme gene polymorphism with diabetic retinopathy and diabetes myocardial infarction].
    Wu SS; Guo QM; Liu GL; Zhang J; Zhao CF; Ning SC; Zhao LN; Yu F; Yi HL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):283-5. PubMed ID: 15192839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anabolic steroid preparations in the complex therapy of diabetic retinopathy].
    Margolis MG; Zefirova GS; Shul'pina NB
    Vestn Oftalmol; 1969; 82(4):64-6. PubMed ID: 5383941
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.